Investigator Agreement Template for the United Arab Emirates

An Investigator Agreement is a fundamental legal contract that governs the relationship between research sponsors and principal investigators conducting clinical trials or medical research studies in the United Arab Emirates. This agreement establishes clear responsibilities, procedures, and compliance requirements that ensure research quality while protecting patient safety and maintaining regulatory compliance with UAE healthcare laws.

When do you need this document?

You need an Investigator Agreement whenever initiating clinical research studies in UAE healthcare facilities. This includes pharmaceutical companies conducting drug trials, medical device manufacturers testing new products, academic institutions pursuing research grants, or contract research organizations managing multi-site studies. The agreement is mandatory before any research activities begin and must be executed between the sponsor and each participating investigator or research site. Healthcare institutions typically require this contract as part of their research approval process, ensuring all parties understand their legal obligations under UAE law.

Key legal considerations

The agreement must clearly define investigator responsibilities including protocol adherence, patient recruitment, data collection, and adverse event reporting. Financial arrangements require transparent disclosure of compensation, budget allocation, and payment schedules to avoid conflicts of interest. Data protection clauses must comply with UAE Federal Law No. 5 of 2019 on Healthcare Data Protection, ensuring patient confidentiality and secure data handling. Intellectual property provisions should address ownership of research findings, publications rights, and patent considerations. The contract must include termination procedures, covering circumstances for early study closure, data retention requirements, and final report obligations. Insurance and liability provisions are crucial, particularly regarding medical malpractice coverage and sponsor indemnification for protocol-related activities.

Legal requirements in United Arab Emirates

UAE law mandates compliance with Federal Law No. 4 of 2016 on Medical Liability, which governs medical practitioners' responsibilities and patient consent requirements during research activities. Cabinet Resolution No. 40 of 2019 establishes specific protocols for research approval and ethics committee reviews that must be referenced in the agreement. Investigators must maintain valid licenses with the Ministry of Health and Prevention and ensure their research activities fall within their scope of practice. The agreement must address UAE Federal Law No. 2 of 2019 on ICT in Healthcare when electronic health records are involved, establishing proper data handling and technology use protocols. Ethics committee approval is mandatory before research commencement, and the agreement should specify requirements for protocol amendments and ongoing compliance monitoring. Additionally, the contract must ensure alignment with international good clinical practice standards while maintaining adherence to UAE-specific regulatory requirements and cultural considerations.